IT Solutions
Data Integrity module
Feb 21 2018
LabWare has developed and launched a new data integrity module for its enterprise LIMS and ELN solution to help drug manufacturers conform to the FDA draft guidance on ‘Data Integrity and Compliance with CGMP’.
The new enhancement to LabWare LIMS & ELN ensures that companies are able to meet current and proposed regulatory guidance regarding the management of data in temporary memory. New and emerging data integrity standards put forth by the U.S. Food and Drug Administration (FDA), U.K. Medicines and Healthcare Products Regulatory Agency (MHRA), and World Health Organization (WHO), which would require the capture of temporary data in electronic records.
The new features are in addition to LabWare current solution that supports a GxP-compliant audit trail based on a full history of analytical testing, including:
Forced Save during manual result entry, to mitigate manipulation of values in temporary memory.
Disabling manual entry when data is captured directly from instrumentation
Forced reviews of Audit Trail entries when exceptions occur, such as result modification
Checksum generation and checking against data records, to detect manipulation.
Date time of data entry
Electronic Signature and mandatory reason for change
Digital Edition
Labmate UK & Ireland 49.2 - March 2024
March 2024
In This Edition Articles - Choosing the right LIMS for your lab: Four key considerations - Pay increases to continue but staff focus on security and training - Building a global culture of...
View all digital editions
Events
Mar 26 2024 Milan, Italy
Mar 27 2024 Lyon, France
Microbiology Society Annual Conference 2024
Apr 08 2024 Edinburgh 2024
Apr 09 2024 Munich, Germany
Apr 10 2024 Helsinki, Finland